PF-07209960

PF-07209960 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07209960, covering 2024-07-29 to 2024-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors [Phase 1]